MENS (Jyong Biotech) Other Current Liabilities: $3.48 Mil (As of Dec. 2025)


MENS Jyong Biotech Ltd MENS
10 GF Score
Price $2.19
! 3 Warning Signs
View Full Analysis

What is Jyong Biotech Other Current Liabilities?

Jyong Biotech MENS -2.45% 10 Other Current Liabilities is $3.48 Mil as of Dec. 2025. GuruFocus rates MENS with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Jyong Biotech's other current liabilities for the quarter that ended in Dec. 2025 was $3.48 Mil.

Jyong Biotech's quarterly other current liabilities increased from Dec. 2024 ($3.33 Mil) to Jun. 2025 ($3.37 Mil) and increased from Jun. 2025 ($3.37 Mil) to Dec. 2025 ($3.48 Mil).

Jyong Biotech's annual other current liabilities declined from Dec. 2023 ($4.99 Mil) to Dec. 2024 ($3.33 Mil) but then increased from Dec. 2024 ($3.33 Mil) to Dec. 2025 ($3.48 Mil).

Jyong Biotech Other Current Liabilities Related Terms

Jyong Biotech Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Jyong Biotech's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jyong Biotech Other Current Liabilities Chart

Jyong Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
0.02 4.22 4.99 3.33 3.48

Jyong Biotech Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial 4.99 3.31 3.33 3.37 3.48
MENS
10GF Score
Jyong Biotech Ltd MENS
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jyong Biotech Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $3.48 Mil mean?
Jyong Biotech (MENS) has a Other Current Liabilities of $3.48 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Jyong Biotech.
Is Jyong Biotech's Other Current Liabilities too high?
Jyong Biotech's current Other Current Liabilities is $3.48 Mil. Overall, Jyong Biotech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Jyong Biotech's Other Current Liabilities compare to ENLV and CNTB?
Jyong Biotech's Other Current Liabilities of $3.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Jyong Biotech. Jyong Biotech's current Other Current Liabilities is $3.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jyong Biotech stock overvalued right now?
Jyong Biotech (MENS) has a current Other Current Liabilities of $3.48 Mil. The current Other Current Liabilities is $3.48 Mil. Jyong Biotech's overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Jyong Biotech (MENS), the current Other Current Liabilities is $3.48 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jyong Biotech Business Description

Address Xintai 5th Road, 23F-3, No. 95, Section 1, Xizhi district, New Taipei, TWN, 221
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
10GF Score

Get the complete analysis for MENS

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.19
Price